Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

By Novella-Maestre Edurne   Carda Carmen   Noguera Inmaculada   Ruiz-Saur Amparo   Garca-Velasco Juan Antonio   Simn Carlos   Pellicer Antonio  

Human Reproduction, Vol. 24, Iss. 5, 2009-05 ,pp. : 1025-1035

Oxford University Press

Access to resources Recommend Favorite

Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice

By Lu Yuan   Nie Jichan   Liu Xishi   Zheng Yu   Guo Sun-Wei  

Human Reproduction, Vol. 25, Iss. 4, 2010-04 ,pp. : 1014-1025

Oxford University Press

Access to resources Recommend Favorite

Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo

By Laschke Matthias W.   Schwender Christine   Scheuer Claudia   Vollmar Brigitte   Menger Michael D.  

Human Reproduction, Vol. 23, Iss. 10, 2008-10 ,pp. : 2308-2318

Oxford University Press

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators and Coronary Heart Disease

By Bian Z.   Nilsson S.   Gustafsson J.-.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 5, 2001-07 ,pp. : 196-202

Elsevier

Access to resources Recommend Favorite

Estrogen and Selective Estrogen Receptor Modulators: Neuroprotection in the Women's Health Initiative Era

By Murphy Stephanie J.   McCullough Louise D.   Littleton-Kearney Marguerite T.   Hurn Patricia D.  

Endocrine Journal, Vol. 21, Iss. 1, 2003-06 ,pp. : 17-26

Humana Press, Inc

Access to resources Recommend Favorite